Patient Registry Software Market size valued at USD 932.20 million in 2021 and expected to reach USD 2,243.58 million by 2028, at a CAGR of 12.8% during the forecast period 2022-2028. Growth of the market for electronic health records (EHRs) as well as several advantageous aspects including tracking list of a medical problem with the patient, management of data of results, or active surveillance system will boost the market growth in coming, owing to lifestyles with population increase with chronic diseases such as cancer, cardiovascular disorders, or others, and ramping up the need of systems to function enormous healthcare statistics are the major driving factors for the market, whereas rising demand for electronic health records (EHRs) and several advantageous factors such as tracking the history of a medical problem with the patient, management of data Moreover, the risk of data breach and a scarcity of qualified IT workers for effectively operating systems are constraining factors for the industry, while high installation and maintenance costs, along with the risk of data theft, would be a difficult element to overcome in the coming years. Furthermore, an increase in clinical studies involving patient data is projected to provide profitable prospects. For the advancement of patient care, patient registry databases are being used to create clinical research in the field of uncommon and chronic illnesses. These databases are critical for determining the viability of clinical trials and assisting with patient recruitment procedures in order to analyze the impact of new therapies. Patient registry databases are used in healthcare institutions such as hospitals and nursing homes to gather and maintain patient information in order to characterize certain disorders or medical problems. In order to fuel development avenues in the approaching years, the major players in the patient registry software market are implementing a variety of techniques. Major corporations use strategic alliances, mergers, product approvals, partnerships, regional expansion, novel product releases, and acquisitions to produce market expansion prospects.